GlassScriptPhysician profile
Chetan Anand
NPI 1649246760
$3,036.97
in general payments reported to CMS, 2019-2025
19 companies · $473 in 2025
The $473 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $405 · 2021: $124 · 2022: $21.22 · 2023: $245 · 2024: $1,630 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,820 · Travel and Lodging: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,820.47 |
| Travel and Lodging | $527.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $813.70 | 2019-2024 | Senza |
| Si-Bone, INC. | $787.72 | 2023-2024 | |
| Medtronic, INC. | $326.77 | 2023-2025 | Intellis Adaptivestim, Percept PC Brainsense, Inceptiv |
| Biotronik Nro, INC. | $306.53 | 2024-2025 | Prospera |
| Alphatec Spine, INC | $143.34 | 2024 | Invictus Mis |
| Abbott Laboratories | $131.55 | 2020-2025 | Freestyle Libre 3 |
| Medtronic USA, INC. | $103.45 | 2020 | |
| Boston Scientific Corporation | $79.27 | 2024-2025 | General - Pain Management |
| Ipsen Biopharmaceuticals, INC | $60.45 | 2019 | |
| Zimmer Biomet Holdings, INC. | $52.05 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Spr Therapeutics, INC | $36.50 | 2024-2025 | Sprint Pns System |
| Globus Medical, INC. | $36.33 | 2025 | Senza |
| Avanos Medical | $30.42 | 2025 | Coolief Cooled Radiofrequency |
| Nalu Medical, INC. | $28.34 | 2023 | Nalu Neurostimulation System |
| Insulet Corporation | $27.80 | 2025 | Omnipod |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $21.39 | 2024 | |
| Alexion Pharmaceuticals, INC. | $18.79 | 2025 | Strensiq |
| Ibsa Pharma INC. | $17.99 | 2025 | Tirosint, Flector, Licart |
| Vertos Medical, INC. | $14.58 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chetan Anand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.